Although the need for sound research on the outcome of mental disease has long been recognized, and although probably no other medical specialty has accumulated such an abundance of statistics as psychiatry, yet the dearth of adequately designed investigations especially in the field of the evaluation of therapy is conspicuous. The literature describing and appraising the results of insulin, metrazol, and electroshock treatment is voluminous. Reports on lobotomy results have also mounted steadily. In spite of these studies the satisfactory evaluation of therapy still remains one of the most troublesome problems of psychiatric research. In reviewing the vast literature of therapeutic results one finds conflicting reports ranging from severe skepticism of the various therapies to inordinate enthusiasm for them. Consequently every clinician can cite a study to support his particular viewpoint on any given therapy. This state of affairs suggests the need for a critical study of the methodology of these evaluation studies with a view towards the improvement of research design in this area in the future.
THE PROBLEM It would be a Herculean task to attempt to record and to review all the 1 The present publication has resulted from a study undertaken by this author during her tenure of a fellowship granted by The Fund for the Advancement of Education. The facilities of Project M586 of the National Institute of Mental Health aided in the preparastudies that have been done on the evaluation of the various somatotherapies, not only because of their excessive number but also because their results, so diversely presented, defy organized classification according to any one uniform plan. It is, therefore, our intention to present a fairly representative group of researches with their results and the techniques by which these have been derived.
The purpose of this study is to examine the available and analyzable data on the outcome of the shock therapies and psychosurgery in order to get an estimate of the effectiveness of these therapies in the treatment of schizophrenia, as it has been reported in the literature. As a result, four types of data have been analyzed: (a) outcome of nonspecific treatment of all psychoses and schizophrenia during the preshock (pre-1930) period; (6) outcome of nonspecific treatment of schizophrenia during the preshock period, as reported after shock therapy became available; (c) outcome of insulin, electroshock, metrazol, and psychosurgical therapies; and (d) results of comparative studies of treated and control groups.
Outcome of Nonspecific Treatment of All Psychoses and Schizophrenia During the Preshock (Pre-1930} Period
In the beginning of the 20th century both in America and abroad, tion of the material on which this study is based.
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interest was directed toward evaluating the outcome of mental disease. Practical considerations, such as the cost of care of the mentally ill to the community, as well as scientific curiosity prompted hospital administrators and doctors to investigate the results of hospitalizing and caring for mental patients. Most studies consisted in the follow-up of total hospital populations over a period of several years after admission to determine the ultimate disposition of these cases. Bond, Fuller, and Pollock were pioneers in this research. All three studied the outcome of mental disease and all three were unanimous in finding a low rate of improvement in dementia praecox patients. 2 We shall review the work of Bond and Fuller in considerable detail.
In several studies Bond (6, 7, 8, 9 ) reported his findings on the then current results for use as a base line or standard by which new therapeutic measures could be judged as they were developed.
Recognizing the scarcity of follow-up results in psy- 2 It would be interesting to determine whether the uniformly low rate of improvement in these early studies was a consequence of the more narrow definition of dementia praecox which Kraepelin introduced, rather than the wider definition introduced later by Bleuler under the term "schizophrenias." chiatric work as compared with surgery, he compiled the data which he had collected mainly at the Pennsylvania Hospital, a private institution. Bond observed that usually the patients were committed to the Hospital after many opportunities for early treatment had been lost because of the families' tendencies to procrastinate. The summary of Bond's early follow-up studies on heterogeneous groups of patients in the preshock period is presented in Table 1 .
In general Bond considered his findings encouraging and observed that, although the cases came late for treatment, if the psychiatrist could still produce recovery in approximately 25% with about at least 15% ameliorated, then he might rightfully feel gratified.
From Table 1 it can be seen that the recovery and improvement rate combined is between 40% and 50%. Bond maintained that these good results with mental patients should be emphasized to counteract the then (1920's) popular impression that mental patients always become worse and that even if they seem to recover they soon break down again. A point that one cannot fail to note here in reviewing Bond's results is the heterogeneity of the patients. All ages, all types of diseases, and individuals with illnesses of varying durations are represented here, but these are followed up for a long period. While Bond was interested primarily in the general outcome for all mental diseases, he mentions specifically that in his groups the most unchanged by treatment were the dementia praecox cases. The above tabulated studies are important for they were later used in several studies as base lines in evaluating some of the results of the shock therapies in the 1930's.
In addition to Bond, Fuller also studied the outcome of mental illness. Among his many surveys during the preshock period, he reported in 1930 on the expectation of hospital life and outcome for mental patients for first admissions to mental hospitals (24) . This extensive survey furnished data on a wide variety of psychoses as well as a report on all psychoses. He included 1,200 patients in each group of psychoses such as Dementia Praecox or Manic Depressive, and 2,400 in the "All Psychoses" group. Fuller presented his statistics in a particularly effective way, giving the results in terms of patients discharged, dead, and still hospitalized at various time intervals up to 15 years. Fuller's findings regarding the outcome of first admissions to a mental hospital are presented in Table 2 .
In Fig. 1 the percentage discharged and not later readmitted for All Psychoses and for Schizophrenia is presented. It will be noted that from 3 months to 15 years there is a rather steady rise in the percentage discharged and not later readmitted for both groups, the rate being slightly higher for All Psychoses than for Schizophrenia. At the end of 5 years, 29.9% in Schizophrenia and 36.9% in the All Psychoses categories respectively are discharged and not later readmitted. At the end of 10 years, 32.2% of the Schizophrenic group and 39.3% of All Psychoses are discharged and not later readmitted, while after 15 years the percentages are 35.3 and 40.9 respectively for Schizophrenia and All Psychoses.
In another survey (25) based on 11,050 patients admitted over a twoyear period to the civil State hospitals of New York, Fuller found that out of every 1,000 patients representing first admissions of all diagnostic categories 87.1% were hospitalized only once, while 12.9% had more than one hospitalization. In 1931 in studying the duration of hospital life for mental patients, Fuller (26) reported the (27) published another report on the outcome of mental disease in 947 patients discharged from the civil State hospitals of New York during the decade following their discharge. As a result of his investigation he was able to estimate that during a ten-year period, out of each 100 patients discharged from the civil State hospitals of New York, 55 would be living in the community, 21 would be resident again in a mental hospital and 23 would have died either in the community or in a mental hospital and 1 out of the total 100 would be located in some type of institution other than a mental hospital. A summary of his findings is presented in Table 4 .
Once again, as in the case of the Bond studies, the groups used by Fuller were heterogeneous. Bond's recovered and improved category in Table 1 Table 5 presents the results of a group of such studies on the outcome of mental disease in patients, mainly schizophrenics, hospitalized during the preshock period. In appraising these results it must be realized that during that era patients received mainly routine hospital care, or what is frequently referred to now as non- Malamud (52) and Solomon maintain that there is no such thing as "spontaneous remission." They contend that every patient gets something out of his hospital stay and that something is what helps in recovery. Therefore, they claim that everything that is done for the patient is in one sense or another treatment, whether or not it is meant to be treatment by the doctor who administers it.
In opposition to this viewpoint, there are those investigators like Stunkard (76) who maintain that in order to evaluate therapeutic effects of a specific therapy it is necessary to contrast it with the expected spontaneous improvement. To prove the effectiveness of a particular therapy one should be able to demonstrate, other factors remaining constant, that the patient makes more progress with the therapy than without it. The essential problem in this "spontaneous remission" controversy revolves around the significance of the term "treatment." These studies of spontaneous remission seem to be measuring the same factors as the studies of the so-called nonspecific treatments. It should be mentioned here that ordinarily nonspecific treatment includes hydrotherapy, recreational therapy, occupational therapy, physical therapy, and even brief interviews with physicians.
In Table 5 we have included the "spontaneous remission" and the nonspecific treatment studies. A review of these investigations reveals very little specification on the part of the authors of the type of patients, duration of illness, duration of followup and of other relevant factors necessary to compare different studies. The earliest study listed in the table, that of Bond and Bracelancl, reports the outcome based on a heterogeneous group. The later studies were based exclusively on patients suffering from schizophrenia, a disease so well represented in all mental hospitals that it offered the greatest challenge to the new therapies. Comparing the over-all results with the results for the schizophrenic group in the Bond and Braceland study, one finds a much higher recovery rate for the heterogeneous group. Improvement in the schizophrenic group is fairly low in all studies. Generally speaking, most of these studies indicate about a 30-40% improvement rate maintained upon follow-up by these so-called spontaneous remissions or by those who have had nonspecific treatment. Similar results have also been reported from abroad by Neumann and Finkenbrink (60) who found 32.9% social remissions after a twenty-year follow-up. The chief difficulty in appraising these results is that most workers have not indicated the duration of the psychosis at the time that the patients came for treatment. From the few studies in which the duration was indicated, it can be seen that there is considerable variability in this factor in the different studies, as in the case of Gelperin's (28) group which included both acute and chronic cases. Such variability makes comparisons very difficult. However, as we shall see presently, the shock period studies of the somatotherapies likewise included individuals who had been ill for varying lengths of time. The statistics that have been presented in the foregoing tables offer only an over-all view.
In summary then, it may be said in respect to the nonspecific treat- Rennie (66) Malamud & Render (52) Rupp & Fletcher (70) Hunt, Feldman, & Fiero (37) Cheney & Drewry (13) Whitehead (80) Bond & Braceland ( Gelperin (28) Guttman, Mayer-Gross, & Slater (30) Romano & Ebaugh (68) Whitehead (80) Cheney & Drewry (13) Rennie ( t Of the 500, 486 were discharged; 5 died in the hospital and 9 remained in the hospital. These 486 were then subsequently followed up.
t Of this group, 10% died; 43% continued in the hospital, and 47% were living outside. § Of the 641, 10.8% died (69), moat of them unimproved. -• Indicates either failure to report or reporting in a manner that could not be tabulated here.
merit of psychotics that studies with a brief follow-up of one year or less, such as those of Fuller, using heterogeneous groups indicate discharge rates and recovery rates of about 27%, increasing with the increase in duration of follow-up. The rates for DP cases are lower, less than 20%. On fifteen-year follow-up Fuller found a discharge rate of 35.3%, while the over-all discharge rate for all psychoses (for those not later readmitted) was 40.9%. The early studies of Bond with heterogeneous groups are similar to Fuller's. Including the young and old, the functional and the organic cases, Bond obtained a recovery rate of about 25% for five-year follow-up and a total improvement rate of about 40% (including recovery and improvement). In Table 5 , one heterogeneous study, that of Bond and Braceland, showed a recovery rate of 35% after five years and a total improvement rate (recovered and improved) of 53%. Most of the other studies, all of which have been with homogeneous groups-'schizophrenics (see Table  5 ), have indicated that about a 40% improvement rate may be expected over a five-year period. The tremendous variation in all of these studies in respect to follow-up, duration of illness, and the like, makes strict comparisons impossible.
Outcome of Insulin, Electroshock,
Metrazol and Psychosurgical Therapies (Without Controls') The introduction of the shock therapies and then, later, of psychosurgery was heralded by interested and hopeful psychiatrists as a great advance. The initial enthusiasm for insulin, metrazol, the elcctroconvulsivc therapies, and psychosurgery as well has, however, been giving way gradually to more caution in most circles since the mid-1940's at which time the five-year follow-up results of the shock therapies and psychosurgery began to appear.
In general, the studies on the outcome of these specific somatotherapies can be considered under two categories, depending on whether or not control groups have been used. The first group which we are discussing here simply reports the outcome of the particular treatment used. Such studies as a rule simply indicate the immediate and/or follow-up status of patients treated with the given therapy. No attempt is made to use a control group. The general implication seems to be that the patients would have been worse if the particular treatment had not been employed. A group of such studies is presented in Table 6 . Robinson (45) Smith et al. (74) Oltman et al. (63) Paster & Holtzman (65) Kane et al. (42) Bennett (4) Wilson (81) Malamud et al, (51) Bond & Rivers (12) Bennett & Wilbur (5) Freeman & Watts (22) Holt (35) MacKinnon (50) Morrow & King (59) Moore et al. (58) Martin ( 
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• Indicates either failure to report or reporting in a manner that could not be tabulated here. (78) Libertson (47) Ziskind et al. (83) Hinko & Lipschutz (32) Tillotson & Sulzbach (79) Tait & Burns (77) Gottlieb & Huston (29) Bond (10) Malzberg ( 
DURATION OF FOLLOW-UP '. YEARS AFTER ADMISSION (NON-SPECIFIC AND CONTROLS)
FIG. 2. OUTCOME OF MENTAL PATIENTS GIVEN NONSPECIFIC TREATMENT (PRESHOCK) AND OF THOSE USED AS CONTROLS (SCHIZOPHRENICS)
Results of Comparative Studies with Treated and Control Groups
While the studies just described were without controls, others have made an attempt to compare untreated groups with those treated with a specific somatotherapy. In these investigations control groups have been assembled from current cases for the particular research in progress, or control data have been obtained from the preshock records of the investigator's own practice or hospital. Table 7 presents a representative group of studies containing treated groups as well as untreated control groups.
Graphic Analysis of Previously Tabulated Results on Somato-
therapies In order to analyze the results of the previously tabulated studies, specifically for schizophrenia, a series of graphs was made. Figure 2 shows the percentage of schizophrenics recovered, much improved, and improved at follow-up intervals up to 5 years after admission. The findings of individual studies and control studies have been shown in the graph, but the lines are drawn through the averages for nonspecific treatment at each follow-up interval in the one case, and through the averages for the con- 
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FIG. 3. OUTCOME OF MENTAL PATIENTS TREATED WITH VARIOUS SOMATOTHERAPIES (SCHIZOPHRENICS)
trols at each follow-up interval in the other. One exception should be pointed out. It will be noted that the nonspecific treatment study at the two-year level (a single study-• 23.57% recovered and improved) drops unusually low and out of line. The point is indicated in the graph, but omitted from the line of averages.
In general the trend is for the nonspecific treatment groups to show a recovered, much improved, and improved rate of about 40% at the end of five years, a finding in conformity with those of Bond and Fuller. It is interesting to note, however, that with the single exception of the oneyear follow-up level, the controls are always poorer than the nonspecific groups, showing a recovered, much improved, and improved rate of only about 25% at the end of five years. One may ask why the controls used in the shock era should be so different. One reason may be that in the shock era only poorer patients, that is, those with unfavorable prognoses, were available as controls, other patients being given the benefit of the specific treatments. There is also a second possibility, namely, that chronic, deteriorated cases may have been selected as controls. In any case the outcome for the controls is strikingly different from that for those given nonspecific treatment in the 1930's. The general findings of these studies of nonspecific treatments and spontaneous remissions should be kept in mind as we turn now to the results that have been reported for the specific somatotherapies-insulin, 
FIG. 4. OUTCOME OF MENTAL PATIENTS TREATED WITH VARIOUS SOMATOTHERAPIES AS COMPARED WITH OUTCOME OF MENTAL PATIENTS GIVEN NONSPECIFIC TREATMENT (?RE-SHOCK) AND THOSE USED AS CONTROLS (SCHIZOPHRENICS)
metrazol, electroconvulsive therapy, and psychosurgery.
Next, the outcome of schizophrenics treated by the various somatotherapies, that is, insulin, metrazol, electroshock, and psychosurgery, was analyzed. These results are presented in Fig. 3 . The percentage of schizophrenics recovered, much improved, and improved in the individual studies at varying follow-up intervals after the termination of treatment, up to five years, is shown in this graph. As in the previous graph, the averages at each interval of follow-up have been computed. The insulin average is indicated as /, electroshock as E, metrazol as M, and psychosurgery as P. The averages for each treatment at each interval constitute the points through which the lines are drawn to represent the outcome for each type of treatment. The graph reveals considerable variability and overlap among the different types of somatotherapies as well as a dearth of studies for longer follow-up periods. Most studies on the outcome of therapy report only immediate outcome and very few go beyond the one-year period. At five years all outcome results for the somatotherapies are poorer than immediate outcome.
In Fig. 4 the lines shown in Fig. 2  and 3 have been combined. Figure 4 shows the average outcome results for schizophrenics treated by each somatotherapy, for the nonspecific treatment and for the controls. The average results for all insulin studies are plotted as I at each interval, metrazol as M, electroshock as E, and psychosurgery as P, nonspecific as N, and the controls as C. The lines drawn through these average points at the various follow-up intervals indicate in all cases better immediate outcome for treated patients (about 50-60%) than for the nonspecific and 
FIG. 5. TREATED vs. UNTREATED PATIENTS (SCHIZOPHRENICS)
controls, but this advantage is not maintained for the treated group on follow-up after five years. Whereas the nonspecific group never shows such striking recovery and improvement rates, the treated groups show more relapses with time, dropping toward the nonspecific rate of about 40% after 5 years following treatment, but never dropping as low as the controls. When all the treatments are averaged into a single line and when the nonspecific and controls are included, we get the results shown in Fig. 5 . For comparison purposes we have also drawn in the nonspecific and control averages. In the graph the letters I, P, E, M, N, and C indicate the average results for all studies of insulin, psychosurgery, electroshock, metrazol, nonspecific treatment, and controls at a given follow-up period (for the somatotherapies from the date of termination of treatment, and for the nonspecific and controls from the day of admission). It will be immediately observed that the recovered, much improved, and improved rate among treated schizophrenics tends to decline as the period after treatment increases. For the untreated the course is more variable, but when the nonspecific treatments are considered alone, they are slightly better than the treated after S years, with a much more even course than the treated during the five-year period.
Although from these results it would appear that somatotherapy 
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FIG. 6. INCIDENCE OF DEATHS AMONG SCHIZOPHRENIC PATIENTS
for schizophrenics offers little advantage when long-term follow-up results are considered, yet another aspect of the problem needs to be considered, that is, the incidence of deaths among the treated and the untreated. Figure 6 presents the percentage of schizophrenics dying in the untreated and the treated groups during follow-up periods, in the case of the treated from the date of the termination of treatment, and in the case of the untreated (nonspecific and control patients) from the clay of admission. The average deaths on follow-up for patients who had been treated with insulin, metrazol, psychosurgery, and electroshock are shown in Fig. 6 . The lines representing average nonspecific and control deaths are also shown. In this graph we can see immediately that the death rate rises steadily in the untreated groups (nonspecific and controls). Fewer patients die in the treated than in the untreated groups. (It should be noted too that psychosurgery contributes considerably more to the death rate than the other therapies.) The saving of life which treatment offers cannot be overlooked, even in the face of failure to produce high recovery and improvement rates. 3 The data presented in these graphs do not permit us to draw any definite conclusions as to the relative merits of any one specific therapy in the treatment of schizophrenia, since the evidence is scattered and since, moreover, not all studies on somatotherapy which we have found in the literature could be graphed in this way (largely because of insufficient information as to follow-up, etc.); nevertheless, they shed some light on the inadequacies of the studies that have been done and they indicate the need for improvement of the research in the evaluation of the somatotherapies (33). Tables 6 and 7 will be considered in terms of the four essentials previously set by one of the present authors (84) as minimum essentials of adequate research design: homogeneity, control groups, follow-up, and specific criteria for evaluating outcome.
AN APPRAISAL OF THE FOREGOING STUDIES IN TERMS OF METHODOLOGY The methodology of the studies listed in
Homogeneity
It can be seen from both Tables 6 and 7 that some investigators continue to include all types of mental diseases in their investigations without specification. While this practice is acceptable if separate outcome results are presented, some give only the total results (44, 58) . Very frequently acute and chronic cases are included in the same study, and total, rather than separate, outcome results are reported. In most cases the length of the illness before treatment is not even mentioned. While most investigators usually give adequate identifying data as to the age, sex, and number of patients, an occasional study does not even clearly specify the disease entity under investigation. From the point of view of research design in general, however, homogeneity is probably the feature least open to criticism in modern evaluations of the somatotherapies.
The Use of Control Groups
This criterion of research design is often not met at all or only very poorly satisfied (15) . In Table 6 there are a large number of studies, no one of which has used any controls. This type of study is commonly found in the literature. The immediate or follow-up results of treatment are presented, the basic assumption being that the patients studied would have been worse if untreated. In many of the studies which have employed controls (see Table 7 ), the difficulty lies in the nature of the controls used. In some investigations old studies such as Bond's have been cited and used as norms against which to compare shock results. These data ought not to be used as standards or base lines since, as we have seen, they were derived from total hospital populations. Moreover, diagnostic criteria have changed and probably the character of the patient population has changed, too, as a consequence of mental health education, interest in psychiatry, and increased use of the specific therapies in private practice as well as in hospitals. The use of the control data of other workers and other hospitals as reported in the literature, no matter how recent, is valueless because of the discrepancy in diagnostic criteria. Yet this practice has not been abandoned by investigators (29) .
Several investigators, appreciating the inadvisability of employing control data from other studies, have assembled controls for their particular research. But a review of Table 7 will reveal that this practice is not without its difficulties. Often such control groups include patients in whom the treatment is contraitidi-
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cated (82, 83) , whose symptoms are too mild for treatment by the particular therapy under investigation (82, 83) , or who are chronic and deteriorated cases. Some control groups include an assortment of all these different types (82, 83) . Occasionally, the nature of the control group is merely described as a comparable group but without shock treatment. No details are given (79) . At times, control cases are selected at random by a secretary (47) . Very often the control groups are not given the same amount of motivation as the treated groups, so that their morale may be lower during the observation period. On that account the groups may not be strictly comparable. Sometimes the control groups or some of their members are given other treatment during the period of follow-up (23) .
Needless to say these practices render the findings of such research worthless. The problem of establishing controls in psychiatric research has provoked much discussion in the literature, some writers taking points of view that are diametrically opposed. Curran (14) has indicated that obtaining controls in psychiatry is an arduous task, for it is not easy to assemble groups of patients who can be validly compared. In discussing electric shock treatment and its results, Reynolds (67) has taken a similar view.
Moreover, Curran argues that it is never possible to get untreated groups, for he feels that it is not possible to determine the nature of a reaction without altering that reaction at least to some extent, since in any medical examination some impressions as well as some recommendations are made.
The selection of controls is no easy matter. First of all, our ignorance of the causes of mental diseases militates against matching controls and treated cases with certainty. Second, it is not right, ethically speaking, to withhold certain treatments, just as it would be wrong to administer certain untried treatments, for research purposes only. One feature which has helped the research worker is the failure of some families to consent to a specific therapy for which a particular patient has been selected. Unfortunately, the attitude of the family may be a factor in the final release of the patient, thus producing a discrepancy between the treated and untreated groups (22) .
Occasionally the objection is raised that the morale of the control groups is lowered by failure to receive the specific therapies. This objection has been met by Notkin (61, 62) , for example, who gave intramuscular injections to control group patients while the treated patients received insulin. This objection may also be adequately met by providing the control group with "total push." In this connection, it is interesting to note that Mettler (57) has urged that three comparable groups be used, if possible: (a) one group should be followed to investigate the degree of spontaneous improvement which may occur; (I) another should receive the specific therapy to be evaluated; (c) if a third group exists, it should be subjected to all the nonspecific aspects of the therapy to be evaluated. Theoretically Mettler's suggestion is sound, but in practice it further complicates the problem by requiring the selection of three comparable groups instead of two. Since the use of controls is imperative in any sound experimentation, this important criterion continues to be one of the troublesome features of measuring the effectiveness of the somatotherapies.
One method is to lay down a mini-mum number of variables on which the treated and the untreated groups should be comparable. Among such fundamental variables are: age, sex, age at onset of illness, type of onset, type of illness, type of treatment, duration of follow-up. Once comparability is attained on these fundamental variables, additional variables on which the control and treated groups may differ can be controlled by analysis of covariance or similar methods, f A list of variables which may be important in determining outcome is currently under study in an investigation of prognosis (Zubin, J., Peretz, D. and Ossipow, S., Psychiatric Prognosis--in preparation).
Follow-up
In both the uncontrolled and the controlled studies, the duration of follow-up is frequently unspecified. In some studies it varies from patient to patient. The duration of follow-up is a prime consideration, for immediate evaluations of the outcome of therapy or evaluations based upon short follow-up periods make no allowance for the possibility of later relapses. Thus the recovery rates in studies that give the patients' status immediately or shortly after termination of treatment are spuriously high. Menninger (56) and Alexander (2) have for this reason both emphasized the importance of the time factor in evaluation studies by stressing how different therapeutic results may appear after varying intervals following treatment. In general, long-term follow-up, preferably a period of five years, is the ideal. Only a few studies meet this requirement (18, 34, 39) . It is of course difficult and expensive to keep each member of a population under observation for so long a period. Furthermore, populations are not static. There are remissions, deaths, and patients lost to the study because of removal from the community. Dorn (16) has cautioned that the validity of a follow-up study is very questionable if each individual is not followed for the maximum possible duration. Naturally it is understandable that all patients cannot always be followed. The investigator should mention how many could be traced after a given follow-up period, but this information is seldom supplied. More commonly, conclusions are based on the number for whom information is available with no reference to missing cases. Obviously this gives rise to biased results.
While we have not indicated in our tables what method of follow-up was employed in each study, it should be mentioned here that in a large number of studies the procedure is rather haphazard. Rarely is it uniform for all patients. As a rule, questionnaires are sent to patients or to their families. Social service or psychiatric interviews are given to some, but not to all. Occasionally in the same study some patients are followed up in every possible way, some in only one way, failing which, the patient is lost to the study. The variation in followup methods for subjects in the same investigation is considerable.
In general the interview is considered preferable to the questionnaire by all workers. Ideally, for re-examination, the psychiatrist as well as the social worker should see the patient, preferably the same psychiatrist and social worker responsible for original examination. Patients' reports of their own status or those obtained from their families, important as they are, should not constitute the sole basis for evaluation.
Another problem of follow-up which is critical is the treatment of deaths.
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Some workers such as Karagulla (43) exclude deaths; others such as Slater (72) include them in computing the improvement rate. In several studies deaths are not even reported. It has been suggested (85) that Jerzey Neyman's (21) mathematical models can provide the real answer to this problem through the computation of net improvement rates from which the influence of deaths and relapses has been eliminated.
Criteria of Evaluation
In reviewing the studies on the outcome of therapy one cannot help being impressed with the number of outcome categories which research workers have been able to devise. Recovery may be variously expressed as complete recovery or social recovery, while improvement may be described in terms of improved, much improved, slightly improved, little improvement, and the like. In our tabulations we have grouped these various headings under the more general captions, Recovered and Improved, Unimproved and Dead. Not only do different investigators use different categories, but they define the same categories differently. Objective terms are needed to express changes in the patient's condition after treatment. Objectivity, however, is difficult to achieve wherever the nature and extent of improvement are obscure, as is usually the case in psychiatric disorders. One must determine whether a specific change in a patient's condition signified improvement. The extent of error in judging the presence of improvement and its degree should be indicated. Gjessing (71) in 1938, after noting the impossibility of keeping meaningful statistics until it is known what a given worker means by the terms "recovered," "improved," "much improved," urged that international standards be defined for these terms. One can only regret, after a review of the current literature, that Gjessing's suggestion was never implemented.
Because of the lack of uniformity and objectivity in reporting outcome, exact comparison of the various studies is difficult. It appears that the only uniform category for all studies is the Dead, although in some studies the number of the dead is not listed separately, being included under other categories according to the status at the time of death. Where deaths are reported, the figures are often presented apologetically, at times with reassuring observations to the effect that death was not really due to the treatment.
In reporting outcome, workers have demonstrated considerable variation in the use of numbers or percentages of patients. Some authors use parole or discharge as the criterion of evaluation. In spite of its limitations, as previously mentioned, this criterion does seem to be about the most satisfactory, since it reduces the classification to a dichotomy. The patient is either in or out. Where there are multiple classifications, they are invariably based upon subjective clinical evaluations with consequent increase in the possibility of error. More recently, as in the Brain Research Project at the New York State Psychiatric Institute, objective rating scales have been employed with a scale of numbers ranging from 1 to 5 (excellent . . . most unfavorable outcome). This lends itself more readily to statistical evaluation without in fact eliminating the subjective character of the rating. Such a rating scale, universally used, would make for uniformity of outcome categories, and by reducing the present variation from study to study, would facilitate comparisons of various investigations.
NEED FOR PLANNED RESEARCH Various suggestions for planned research (73) have been formulated from time to time by different investigators. Thus Luff (49) urged close cooperation between workers in different mental hospitals, pointing to the kind of cooperative inquiry employed successfully in cancer research as an example of what could be done. In 1937 Luff suggested that mental hospitals keep standard records and institute follow-up systems such as are maintained for cancer study. Systematic research seems to be just as necessary in the field of mental disease as for physical disease. After reviewing the literature for the present paper, however, the writers are left with the impression that a large percentage of the articles on the evaluation of the somatotherapies was inspired by the mere fact that certain data had been collected. An article in a psychiatric journal seemed a natural way to make use of them. In other words, the planning often seems to have come last. This is probably the reason why a large number of investigations reported in the literature on evaluation of therapy appear purposeless, disorganized, and poorly executed, despite their impressive arrays of statistics. Various complaints have been raised against these surveys of therapeutic results. Some critics, like Israel and Johnson (41) , have felt that prevailing statistics do not accurately portray the really hopeful prognosis for the mentally ill. Others have complained that present statistics are too optimistic.
As early as 1930, Sakel (71) , alarmed by the already numerous statistical reports on shock therapies, cautioned that psychiatrists should not place too much reliance on statistics because of the lack of knowledge as to the true nature of the mental diseases which they were studying, especially schizophrenia. In his opinion most of the researchers were dealing with symptoms, for "they had no test to define the nature of schizophrenia, and therefore they could not set up a test of 'cured' and 'not cured'." In l ; ke vein, Alexander (1) has complained about "the delirium of numbers" in personality research. Similarly, Lewis (46) in discussing the status of shock therapy in 1943 emphasized the disagreement in results and reminded his colleagues that statistical manipulation of unreliable data is fruitless. Moreover, there seems to be a clear division between one group of workers who rely on clinical judgment and another group who enlist statistics in appraising the results of the psychiatric therapies. In any case, research evaluating the outcome of therapy needs careful planning.
SUMMARY
This review of the literature evaluating the somatotherapies reveals that a large number of studies have been inadequately planned and poorly designed.
Several serious defects have been observed. Among them are: (a) lack of homogeneity of patients studied in respect to diagnostic classification, age, duration of illness, and follow-up; (b) too brief, poorly executed, or inadequately reported follow-up; (c) lack of controls or poorly selected controls; (d) inadequate, illdefined, or unspecified criteria for evaluating outcome; (e) failure to report deaths, especially for follow-up studies, or inclusion of the dead under the category representing their status at the time of death.
In spite of their individual limita-tions these studies, taken in the aggregate, have demonstrated shortterm advantages but have not demonstrated definitely significant advantages for the specific somatotherapies in the long run. Our review of the literature, however, has revealed the following facts: 1. Where only immediate outcome is reported, there seems to be a distinct advantage for treated groups as compared with untreated ones. Their stay in the hospital is reduced. The death rate is apparently lower for the treated. Such results should not be underestimated, for they may mean that suicides and deaths from inanition have been reduced among depressed patients; that human suffering has been alleviated and that private and state funds for hospital care have been saved even though relapses do occur. The somatotherapies help to save human life.
2. Long-term follow-up studies have not generally shown better results for the treated over the untreated in terms of recovery and improvement. The recovery rate still hovers around 35% to 40%. More patients tend to recover in nonspecific groups (and even in the control groups) after five years, whereas more relapses occur among the treated patients.
3. Generally speaking, the specific somatotherapies have seemed to work better with patients whose illness is of short duration (we have not taken up the problem of duration of illness in this paper). Therefore, it may be that these therapies merely accelerate the improvement process in those who would have recovered spontaneously anyway. Even this, however, must be recognized as a real advantage. 4 . It is likely that if better prognostic indicators for the efficacy of each therapy were available, the results for each of the therapies would excel the outcome of the nonspecific therapies.
Finally, the present analysis of data in the literature has indicated that studies evaluating therapy must contain the following minimal information, if adequate comparisons are to be made: sex, age at onset of illness, type of onset (sudden or insidious), age at the time of treatment, type of treatment, duration of followup, and an accurate report of deaths. In comparative studies the selection of controls matched on the abovementioned factors is a necessity. Future research on the evaluation of the outcome of therapy should be designed to meet these requirements and should become more exact (36) .
